Raltegravir labels and packages: Difference between revisions
No edit summary |
|||
| Line 22: | Line 22: | ||
60 Tablets | 60 Tablets | ||
{| | {| | ||
| Line 28: | Line 30: | ||
|- | |- | ||
|} | |} | ||
| Line 47: | Line 50: | ||
60 Tablets | 60 Tablets | ||
{| | {| | ||
| Line 53: | Line 58: | ||
|- | |- | ||
|} | |} | ||
PRINCIPAL DISPLAY PANEL - 25 mg Bottle Label | PRINCIPAL DISPLAY PANEL - 25 mg Bottle Label | ||
| Line 79: | Line 86: | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== | ||
Latest revision as of 01:13, 10 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels and Packages
PRINCIPAL DISPLAY PANEL - 400 mg Bottle Label
NDC 0006-0227-61
Isentress® (raltegravir) tablets
400 mg
Each tablet contains 434.4 mg raltegravir potassium, equivalent to 400 mg raltegravir.
USUAL DOSAGE: See Package Insert.
Rx only
60 Tablets
| [[File:|800px|thumb]] |
PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label
NDC 0006-0477-61
Isentress® (raltegravir) CHEWABLE Tablets
100 mg
For Pediatric Patients 2 to less than 12 Years of Age
Phenylketonurics: contains phenylalanine (a component of aspartame) 0.10 mg per 100 mg chewable tablet.
Rx only
60 Tablets
| [[File:|800px|thumb]] |
PRINCIPAL DISPLAY PANEL - 25 mg Bottle Label
NDC 0006-0473-61
Isentress® (raltegravir) CHEWABLE Tablets
25 mg
For Pediatric Patients 2 to less than 12 Years of Age
Phenylketonurics: contains phenylalanine (a component of aspartame) 0.05 mg per 25 mg chewable tablet.
Rx only
60 Tablets[1]
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.